{"entity":{"type":"insider","cik":"0001837586","url":"/insider/0001837586","json_url":"/insider/0001837586.json","name":"Thompson Kimberly Kraig","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":90,"n_filings":74,"first":"2021-04-02","last":"2022-07-21","span_basis":"filed_date"},"name_variants":[{"name":"Thompson Kimberly Kraig","source":"filing","n_filings":74,"first_seen":"2021-04-02","last_seen":"2022-07-21"}],"transactions":[{"id":6654375,"accession":"0001493152-22-020038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-020038","line_url":"/filing/0001493152-22-020038#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":201587924.0,"shares_owned_after_display":"201,587,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-21","scope":"insider"},{"id":6654373,"accession":"0001493152-22-020038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-020038","line_url":"/filing/0001493152-22-020038#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":201707924.0,"shares_owned_after_display":"201,707,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-21","scope":"insider"},{"id":6450932,"accession":"0001493152-22-019832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-019832","line_url":"/filing/0001493152-22-019832#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79900.0,"shares_display":"79,900","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":201757924.0,"shares_owned_after_display":"201,757,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-18","filed_date":"2022-07-19","scope":"insider"},{"id":6450929,"accession":"0001493152-22-019832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-019832","line_url":"/filing/0001493152-22-019832#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":201837824.0,"shares_owned_after_display":"201,837,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-19","scope":"insider"},{"id":6625928,"accession":"0001493152-22-019444","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-019444","line_url":"/filing/0001493152-22-019444#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11500.0,"shares_display":"11,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":201887824.0,"shares_owned_after_display":"201,887,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-13","filed_date":"2022-07-15","scope":"insider"},{"id":6781371,"accession":"0001493152-22-019177","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-019177","line_url":"/filing/0001493152-22-019177#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":201899324.0,"shares_owned_after_display":"201,899,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-11","filed_date":"2022-07-13","scope":"insider"},{"id":6155606,"accession":"0001493152-22-019012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-019012","line_url":"/filing/0001493152-22-019012#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":201999324.0,"shares_owned_after_display":"201,999,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-11","scope":"insider"},{"id":6155604,"accession":"0001493152-22-019012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-019012","line_url":"/filing/0001493152-22-019012#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202039324.0,"shares_owned_after_display":"202,039,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-07","filed_date":"2022-07-11","scope":"insider"},{"id":6861236,"accession":"0001493152-22-018805","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-018805","line_url":"/filing/0001493152-22-018805#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202059324.0,"shares_owned_after_display":"202,059,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-07","scope":"insider"},{"id":6861233,"accession":"0001493152-22-018805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-018805","line_url":"/filing/0001493152-22-018805#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202119324.0,"shares_owned_after_display":"202,119,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-07","scope":"insider"},{"id":6697146,"accession":"0001493152-22-018386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-018386","line_url":"/filing/0001493152-22-018386#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202139324.0,"shares_owned_after_display":"202,139,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-29","filed_date":"2022-07-01","scope":"insider"},{"id":6131388,"accession":"0001493152-22-018110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-018110","line_url":"/filing/0001493152-22-018110#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202159324.0,"shares_owned_after_display":"202,159,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-28","filed_date":"2022-06-29","scope":"insider"},{"id":6131383,"accession":"0001493152-22-018110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-018110","line_url":"/filing/0001493152-22-018110#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202189324.0,"shares_owned_after_display":"202,189,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6625906,"accession":"0001493152-22-017718","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-017718","line_url":"/filing/0001493152-22-017718#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202239324.0,"shares_owned_after_display":"202,239,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-24","scope":"insider"},{"id":6625904,"accession":"0001493152-22-017718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-017718","line_url":"/filing/0001493152-22-017718#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202269324.0,"shares_owned_after_display":"202,269,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-24","scope":"insider"},{"id":6898449,"accession":"0001493152-22-017598","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-017598","line_url":"/filing/0001493152-22-017598#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202349324.0,"shares_owned_after_display":"202,349,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-22","filed_date":"2022-06-23","scope":"insider"},{"id":6898445,"accession":"0001493152-22-017598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-017598","line_url":"/filing/0001493152-22-017598#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180000.0,"shares_display":"180,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202379324.0,"shares_owned_after_display":"202,379,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-23","scope":"insider"},{"id":6544414,"accession":"0001493152-22-017382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-017382","line_url":"/filing/0001493152-22-017382#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202559324.0,"shares_owned_after_display":"202,559,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider"},{"id":6155579,"accession":"0001493152-22-017173","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-017173","line_url":"/filing/0001493152-22-017173#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202659324.0,"shares_owned_after_display":"202,659,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-17","scope":"insider"},{"id":6181583,"accession":"0001493152-22-016459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-016459","line_url":"/filing/0001493152-22-016459#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202669324.0,"shares_owned_after_display":"202,669,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":6861200,"accession":"0001493152-22-016182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-016182","line_url":"/filing/0001493152-22-016182#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202689324.0,"shares_owned_after_display":"202,689,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6224126,"accession":"0001493152-22-015845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-015845","line_url":"/filing/0001493152-22-015845#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202699824.0,"shares_owned_after_display":"202,699,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-03","scope":"insider"},{"id":6224123,"accession":"0001493152-22-015845","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-015845","line_url":"/filing/0001493152-22-015845#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202709824.0,"shares_owned_after_display":"202,709,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-03","scope":"insider"},{"id":6274365,"accession":"0001493152-22-015609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-015609","line_url":"/filing/0001493152-22-015609#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202729824.0,"shares_owned_after_display":"202,729,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-01","scope":"insider"},{"id":6544399,"accession":"0001493152-22-015366","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-22-015366","line_url":"/filing/0001493152-22-015366#line-3","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202759824.0,"shares_owned_after_display":"202,759,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-27","scope":"insider"},{"id":6544397,"accession":"0001493152-22-015366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-015366","line_url":"/filing/0001493152-22-015366#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202769824.0,"shares_owned_after_display":"202,769,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider"},{"id":6544393,"accession":"0001493152-22-015366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-015366","line_url":"/filing/0001493152-22-015366#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202794824.0,"shares_owned_after_display":"202,794,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-27","scope":"insider"},{"id":6391950,"accession":"0001493152-22-015044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-015044","line_url":"/filing/0001493152-22-015044#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202824824.0,"shares_owned_after_display":"202,824,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":6450871,"accession":"0001493152-22-014805","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-014805","line_url":"/filing/0001493152-22-014805#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202844824.0,"shares_owned_after_display":"202,844,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":6450868,"accession":"0001493152-22-014805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-014805","line_url":"/filing/0001493152-22-014805#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15048.0,"shares_display":"15,048","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202869824.0,"shares_owned_after_display":"202,869,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider"},{"id":6391923,"accession":"0001493152-22-014493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-014493","line_url":"/filing/0001493152-22-014493#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202884872.0,"shares_owned_after_display":"202,884,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"},{"id":6391919,"accession":"0001493152-22-014493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-014493","line_url":"/filing/0001493152-22-014493#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202904872.0,"shares_owned_after_display":"202,904,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6091399,"accession":"0001493152-22-013860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-013860","line_url":"/filing/0001493152-22-013860#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202924872.0,"shares_owned_after_display":"202,924,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider"},{"id":6091393,"accession":"0001493152-22-013860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-013860","line_url":"/filing/0001493152-22-013860#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202947372.0,"shares_owned_after_display":"202,947,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-16","scope":"insider"},{"id":6514124,"accession":"0001493152-22-013052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-013052","line_url":"/filing/0001493152-22-013052#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202967372.0,"shares_owned_after_display":"202,967,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-11","filed_date":"2022-05-12","scope":"insider"},{"id":6514120,"accession":"0001493152-22-013052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-013052","line_url":"/filing/0001493152-22-013052#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202987372.0,"shares_owned_after_display":"202,987,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-12","scope":"insider"},{"id":6450859,"accession":"0001493152-22-012530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-012530","line_url":"/filing/0001493152-22-012530#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202997372.0,"shares_owned_after_display":"202,997,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-06","filed_date":"2022-05-09","scope":"insider"},{"id":6327765,"accession":"0001493152-22-012378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-012378","line_url":"/filing/0001493152-22-012378#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11400.0,"shares_display":"11,400","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":202999372.0,"shares_owned_after_display":"202,999,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-04","filed_date":"2022-05-06","scope":"insider"},{"id":6949949,"accession":"0001493152-22-012110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-012110","line_url":"/filing/0001493152-22-012110#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203010772.0,"shares_owned_after_display":"203,010,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-03","filed_date":"2022-05-04","scope":"insider"},{"id":6949945,"accession":"0001493152-22-012110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-012110","line_url":"/filing/0001493152-22-012110#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203030772.0,"shares_owned_after_display":"203,030,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-04","scope":"insider"},{"id":6246326,"accession":"0001493152-22-011803","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-011803","line_url":"/filing/0001493152-22-011803#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203042772.0,"shares_owned_after_display":"203,042,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-02","scope":"insider"},{"id":6347001,"accession":"0001493152-22-011608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-011608","line_url":"/filing/0001493152-22-011608#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":194795.0,"shares_display":"194,795","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203062772.0,"shares_owned_after_display":"203,062,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-04-29","scope":"insider"},{"id":6450849,"accession":"0001493152-22-011442","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-011442","line_url":"/filing/0001493152-22-011442#line-2","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203257567.0,"shares_owned_after_display":"203,257,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-27","filed_date":"2022-04-28","scope":"insider"},{"id":6450846,"accession":"0001493152-22-011442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-011442","line_url":"/filing/0001493152-22-011442#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50044.0,"shares_display":"50,044","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203307567.0,"shares_owned_after_display":"203,307,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-26","filed_date":"2022-04-28","scope":"insider"},{"id":4635441,"accession":"0001493152-21-020705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-020705","line_url":"/filing/0001493152-21-020705#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36938.0,"shares_display":"36,938","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203357609.0,"shares_owned_after_display":"203,357,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-19","scope":"insider"},{"id":5296120,"accession":"0001493152-21-018883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-018883","line_url":"/filing/0001493152-21-018883#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203394547.0,"shares_owned_after_display":"203,394,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-06","scope":"insider"},{"id":4232762,"accession":"0001493152-21-018191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-018191","line_url":"/filing/0001493152-21-018191#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203430547.0,"shares_owned_after_display":"203,430,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-30","scope":"insider"},{"id":5375607,"accession":"0001493152-21-018087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-018087","line_url":"/filing/0001493152-21-018087#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110000.0,"shares_display":"110,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203530547.0,"shares_owned_after_display":"203,530,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-29","scope":"insider"},{"id":5375605,"accession":"0001493152-21-017763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-017763","line_url":"/filing/0001493152-21-017763#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203640547.0,"shares_owned_after_display":"203,640,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-26","scope":"insider"},{"id":4143807,"accession":"0001493152-21-017641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-21-017641","line_url":"/filing/0001493152-21-017641#line-1","is_derivative":false,"issuer_cik":"0001413119","issuer_name":"Kraig Biocraft Laboratories, Inc","issuer_ticker":"KBLB","issuer_name_source":null,"issuer_url":"/issuer/0001413119","owner_cik":"0001837586","owner_name":"Thompson Kimberly Kraig","owner_url":"/insider/0001837586","role":"Director, Officer (CEO & CFO), Ten percent owner","officer_title":"CEO & CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":203650547.0,"shares_owned_after_display":"203,650,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-23","scope":"insider"}],"next_cursor":"2021-07-22|4143807","ledger_fault":false,"count":{"value":90,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":90,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":90},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001413119","name":"Kraig Biocraft Laboratories, Inc","url":"/issuer/0001413119","role":"Director, Officer (CEO & CFO), Ten percent owner","n_filings":74,"first_seen":"2021-04-02","last_seen":"2022-07-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001837586","retrieved_at":"2026-08-22T00:42:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}